Theresa Janke
2021
In 2021, Theresa Janke earned a total compensation of $2.6M as Chief of Staff at 4D Molecular Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $129,360 |
|---|---|
| Option Awards | $2,048,585 |
| Salary | $385,000 |
| Other | $9,750 |
| Total | $2,572,695 |
Janke received $2M in option awards, accounting for 80% of the total pay in 2021.
Janke also received $129.4K in non-equity incentive plan, $385K in salary and $9.8K in other compensation.
Rankings
In 2021, Theresa Janke's compensation ranked 5,048th out of 12,412 executives tracked by ExecPay. In other words, Janke earned more than 59.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,048 out of 12,412 | 59th |
Division Manufacturing | 2,121 out of 5,498 | 61st |
Major group Chemicals And Allied Products | 906 out of 2,374 | 62nd |
Industry group Drugs | 810 out of 2,095 | 61st |
Industry Biological Products, Except Diagnostic Substances | 203 out of 452 | 55th |
Source: SEC filing on April 13, 2022.
Janke's colleagues
We found three more compensation records of executives who worked with Theresa Janke at 4D Molecular Therapeutics in 2021.